Facebook Linkedin Tumblr Twitter
Home Featured Page 109

Featured

Featured posts

Latest

Here’s Our Take On Neurocrine Biosciences, Inc. (NASDAQ:NBIX)’s Ingrezza

- 0
recovery

TESARO Inc (NASDAQ:TSRO): Here’s Our Take On The Data

- 0

Otonomy Inc (NASDAQ:OTIC): Pivotal Data In Focus

- 0

What’s The Deal Between MetaStat Inc. (OTCMKTS:MTST) And Celgene Corporation (NASDAQ:CELG)?

David Rich - 0
FDA

Inside the FDA: Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s Psoriasis Drug, Brodalumab.

- 2

Here’s Our RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) Yeliva Phase II...

Roger Hannington - 0

Here’s What Happened With Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Tenax Therapeutics...

- 0

Here Are Two Dates To Watch In Biotech This October

- 0

Here’s Why Biodel Inc (NASDAQ:BIOD) Just Gained, And What It Means

- 0

Two Biotech Companies That Have Taken A Hit This Week

- 0
1...108109110...148Page 109 of 148

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© Market Exclusive 2019